RNU6-523P

Across TCGA pan-cancer cohorts, RNU6-523P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-523P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-523P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-523P expression acts as an unfavorable survival marker.

STAD, KIRC, and BLCA are the cancer types where RNU6-523P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.191	0.427	.003	108	view →
KIRC	DFS	Tertile	III,IV	0.586	0.749	.008	63	view →
BLCA	OS	Tertile	All	0.185	0.618	.017	45	view →
SKCM	OS	Tertile	II,III,IV	0.344	0.736	.017	45	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
THCA	OS	Tertile	II,III,IV	0.240	0.829	.011	27	view →
ACC	OS	Tertile	All	0.118	0.624	.038	18	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-523P–STAD (DFS)

Open the STAD breakdown →